MENOPAUSE SOCIETY CERTIFIED PRACTITIONER
(MSCP) LATEST UPDATED 2026-2027 ACTUAL FINAL
PRACTICE EXAM WITH ALL POSSIBLE MOST TESTED
100 PRACTICE QUESTIONS AND 100% CORRECT
VERIFIED ANSWERS WITH DETAILED RATIONALES
PLUS CERTIFIED ANSWER KEY RATED A+ MOST
RECENT!!!
This practice exam consists of 100 multiple-choice
questions designed to assess knowledge across the
five domains of the MSCP certification blueprint:
Physiology and Pathophysiology of the Menopause
Transition, Symptoms and Concerns, Health
Disorders in Midlife, Treatment Options, and
Preventive Care and Counseling. Questions are
based on current evidence and guidelines from The
Menopause Society, ACOG, and other relevant
organizations. Answers and detailed rationales are
provided to reinforce learning.
,1. A 52-year-old woman presents with a 6-month
history of irregular menstrual cycles, with the most
recent two cycles being 65 and 72 days apart. She
reports occasional hot flashes. According to the
STRAW+10 staging system, which stage best
describes her status?
A. Early menopause transition (Stage -2)
B. Late menopause transition (Stage -1)
C. Early postmenopause (Stage +1a)
D. Late reproductive years (Stage -3b)
Answer: B
Rationale: The STRAW+10 system defines the late
menopause transition (Stage -1) as the period with
two or more skipped cycles and at least one
intermenstrual interval of 60 days or more. The
early transition (Stage -2) is characterized by a
persistent difference of ≥7 days in consecutive cycle
lengths. Postmenopause is only confirmed after 12
months of amenorrhea.
2. A 48-year-old woman in the early menopause
transition (STRAW -2) asks about her fertility.
,Which hormonal change best explains the reduced
fertility and cycle irregularity during this phase?
A. A steady decline in estradiol levels leading to
anovulation
B. A decrease in anti-Müllerian hormone (AMH) and
ovarian follicular pool, with elevated FSH
C. A sudden drop in progesterone levels causing
luteal phase defects
D. An increase in inhibin B leading to pituitary
suppression
Answer: B
Rationale: AMH, produced by granulosa cells of
growing follicles, is a marker of ovarian reserve and
declines as the follicle pool depletes, making it an
excellent predictor of approaching menopause. The
early transition is characterized by declining ovarian
reserve, rising FSH (often initially due to decreased
inhibin B), and falling AMH. Estradiol levels may be
variable and can even be elevated due to LOOP
events.
, 3. What is the clinical definition of Primary Ovarian
Insufficiency (POI)?
A. Amenorrhea for 12 months in a woman under
age 45
B. Amenorrhea, elevated FSH >25 mIU/mL on two
occasions, and age under 40
C. The final menstrual period occurring between
ages 40 and 45
D. A sudden cessation of menses with severe
vasomotor symptoms at age 42
Answer: B
Rationale: POI is defined as amenorrhea of at least
4 months' duration, with two FSH levels in the
menopausal range (>25 mIU/mL) at least one
month apart, occurring before the age of 40. It is
distinguished from early menopause, which occurs
between ages 40 and 45. Hormone therapy is
strongly recommended for women with POI until at
least the average age of natural menopause (~51
years) to mitigate long-term health risks.
(MSCP) LATEST UPDATED 2026-2027 ACTUAL FINAL
PRACTICE EXAM WITH ALL POSSIBLE MOST TESTED
100 PRACTICE QUESTIONS AND 100% CORRECT
VERIFIED ANSWERS WITH DETAILED RATIONALES
PLUS CERTIFIED ANSWER KEY RATED A+ MOST
RECENT!!!
This practice exam consists of 100 multiple-choice
questions designed to assess knowledge across the
five domains of the MSCP certification blueprint:
Physiology and Pathophysiology of the Menopause
Transition, Symptoms and Concerns, Health
Disorders in Midlife, Treatment Options, and
Preventive Care and Counseling. Questions are
based on current evidence and guidelines from The
Menopause Society, ACOG, and other relevant
organizations. Answers and detailed rationales are
provided to reinforce learning.
,1. A 52-year-old woman presents with a 6-month
history of irregular menstrual cycles, with the most
recent two cycles being 65 and 72 days apart. She
reports occasional hot flashes. According to the
STRAW+10 staging system, which stage best
describes her status?
A. Early menopause transition (Stage -2)
B. Late menopause transition (Stage -1)
C. Early postmenopause (Stage +1a)
D. Late reproductive years (Stage -3b)
Answer: B
Rationale: The STRAW+10 system defines the late
menopause transition (Stage -1) as the period with
two or more skipped cycles and at least one
intermenstrual interval of 60 days or more. The
early transition (Stage -2) is characterized by a
persistent difference of ≥7 days in consecutive cycle
lengths. Postmenopause is only confirmed after 12
months of amenorrhea.
2. A 48-year-old woman in the early menopause
transition (STRAW -2) asks about her fertility.
,Which hormonal change best explains the reduced
fertility and cycle irregularity during this phase?
A. A steady decline in estradiol levels leading to
anovulation
B. A decrease in anti-Müllerian hormone (AMH) and
ovarian follicular pool, with elevated FSH
C. A sudden drop in progesterone levels causing
luteal phase defects
D. An increase in inhibin B leading to pituitary
suppression
Answer: B
Rationale: AMH, produced by granulosa cells of
growing follicles, is a marker of ovarian reserve and
declines as the follicle pool depletes, making it an
excellent predictor of approaching menopause. The
early transition is characterized by declining ovarian
reserve, rising FSH (often initially due to decreased
inhibin B), and falling AMH. Estradiol levels may be
variable and can even be elevated due to LOOP
events.
, 3. What is the clinical definition of Primary Ovarian
Insufficiency (POI)?
A. Amenorrhea for 12 months in a woman under
age 45
B. Amenorrhea, elevated FSH >25 mIU/mL on two
occasions, and age under 40
C. The final menstrual period occurring between
ages 40 and 45
D. A sudden cessation of menses with severe
vasomotor symptoms at age 42
Answer: B
Rationale: POI is defined as amenorrhea of at least
4 months' duration, with two FSH levels in the
menopausal range (>25 mIU/mL) at least one
month apart, occurring before the age of 40. It is
distinguished from early menopause, which occurs
between ages 40 and 45. Hormone therapy is
strongly recommended for women with POI until at
least the average age of natural menopause (~51
years) to mitigate long-term health risks.
